Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05649020

ED50 of Intratecal Prilocaine in Ultrasound Fusion Prostate Biopsy

Conditions: Evaluate Requirements of 2% Prilocaine in MR-UF Prostate Biopsy

Sex: Male

Ages: 18 Years – 85 Years

Phase: PHASE4

Enrollment: 90

Sponsor: Hospital General Universitario Gregorio Marañon

Location: Spain

Summary

The aim of the present study was to determine the ED50 and ED90 of intrathecal hyperbaric 2% prilocaine (HP) for patients undergoing ambulatory prostate biopsy via magnetic resonance imaging (MRI)/ultrasound fusion.

Eligibility Criteria

Inclusion Criteria:ASA II-III patients Aged 18-85 years Prostate fusion biopsy procedure Scheduled to ambulatory surgery Signed informed consentExclusion Criteria:Standard contraindications to neuraxial blockade, coagulopathy, site infection, neurological impairment, known allergy to local anesthetics. Refusal of the patient to participate in the study.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05649020). StuddyBuddy aggregates publicly available trial information.